Skip to main content
. 2015 May 12;8:7–14. doi: 10.4137/NMI.S23233

Figure 1.

Figure 1

Comparison of zinc transporters and MT1 mRNA abundance from PBMCs at baseline and following 23 days of 20 mg Zn/d or placebo to adult women in rural Sidama southern Ethiopia (paired samples n = 6–9). (A) Placebo group (Cyclophilin B, Mean Cq = 21.4). (B) Zinc-supplemented group (Cyclophilin B, Mean Cq = 21.0). The relative abundance of mRNA was determined using the CT method with Cyclophilin B serving as the invariant control. Numbers beneath gene names indicates Cq (quantitative cycle) obtained for baseline measurement. Asterisk indicates statistical significance between pre- and post-zinc measurement (P < 0.05). Error bars show standard error of the mean.